Aldactone and aspartate aminotransferase increased Patient Reports February 11, 2012

Aldactone Side Effects Report #4695048-6
Aldactone side effect was reported by a Consumer or non-health professional from on June 06, 2005. Female patient, 68 years of age, weighting 81.57 lb, was diagnosed with urinary retention, angina pectoris, prophylaxis, muscle spasms and was treated with Aldactone. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, aspiration, atrial fibrillation , blood albumin decreased, blood chloride decreased, blood chloride increased, blood cholesterol increased, blood creatine phosphokinase increased. Aldactone dosage: unknown. During the same period patient was treated with DILTIAZEM, DILTIAZEM HYDROCHLORIDE. Patient died on 05/20/2002.

Aldactone Side Effects Report #5127463-0
Aldactone side effect was reported by a Pharmacist from SPAIN on Sept 26, 2006. Female patient, 73 years of age, was diagnosed with renal failure chronic, pruritus and was treated with Aldactone. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood potassium decreased, encephalopathy, gamma-glutamyltransferase increased, haematocrit decreased. Aldactone dosage: (100 MG, EVERY DAY); ORAL. During the same period patient was treated with FUROSEMIDE, EBASTINE, OMEPRAZOLE, NORFLOXACIN, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Aldactone Side Effects Report #4613240-3
Aldactone side effect was reported by a Physician from on Mar 03, 2005. Male patient, 78 years of age, was diagnosed with ill-defined disorder and was treated with Aldactone. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, haemoglobin decreased, jaundice , neutropenia. Aldactone dosage: unknown. During the same period patient was treated with GLICLAZIDE, FUROSEMIDE, ALFUZOSIN, OMEPRAZOLE, ENOXAPARIN. Patient recovered.

Aldactone Side Effects Report #4745304-8
Aldactone side effect was reported by a Physician from FRANCE on Aug 04, 2005. Male patient, 78 years of age, was diagnosed with ill-defined disorder and was treated with Aldactone. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, jaundice , neutropenia, pancytopenia, white blood cell count increased. Aldactone dosage: unknown. During the same period patient was treated with GLICLAZIDE, FUROSEMIDE, OMEPRAZOLE, ENOXAPARIN, ALFUZOSIN. Patient recovered.


Aldactone Side Effects Report #4838274-5
Aldactone side effect was reported by a Pharmacist from JAPAN on Nov 14, 2005. Female patient was diagnosed with ill-defined disorder and was treated with Aldactone. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cardiac failure, gamma-glutamyltransferase increased, hepatic congestion. Aldactone dosage: unknown. Patient recovered.

Aldactone Side Effects Report #4854477-8
Aldactone side effect was reported by a Pharmacist from JAPAN on Nov 30, 2005. Male patient was diagnosed with ill-defined disorder and was treated with Aldactone. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic congestion. Aldactone dosage: 50 MG QD ORAL. Patient recovered.

Aldactone Side Effects Report #5141003-1
Aldactone side effect was reported by a Physician from JAPAN on Oct 16, 2006. Female patient, 57 years of age, was diagnosed with hypertension and was treated with Aldactone. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased. Aldactone dosage: 50 MG, ORAL. During the same period patient was treated with DIART, CONIEL, IMPROMEN, AKINETON, METFORMIN HYDROCHLORIDE. Patient recovered.

Aldactone Side Effects Report #4844957-3
Aldactone side effect was reported by a Physician from FRANCE on Nov 16, 2005. Female patient, 99 years of age, weighting 147.7 lb, was diagnosed with cardiac failure, agitation and was treated with Aldactone. After drug was administered, patient experienced the following side effects: abdominal distension, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood urea increased, c-reactive protein increased, crepitations, dehydration, depressed level of consciousness. Aldactone dosage: 25 MG (25 MG), ORAL. During the same period patient was treated with MIRTAZAPINE, RISPERDAL, INSULATARD NPH, ANTALVIC, ASPIRIN, SPECIAFOLDINE, MOVICOL. Patient was hospitalized. Patient recovered.

Aldactone Side Effects Report #5197687-5
Aldactone side effect was reported by a Physician from JAPAN on Dec 15, 2006. Female patient, 69 years of age, was diagnosed with ascites, gastric ulcer and was treated with Aldactone. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, condition aggravated, gastric ulcer, hepatic function abnormal, shock haemorrhagic. Aldactone dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with LANSOPRAZOLE, FUROSEMIDE, PALUNOTOL, LIVACT. Patient died on 12/03/2006.


Aldactone Side Effects Report #5140842-0
Aldactone side effect was reported by a Health Professional from FRANCE on Oct 16, 2006. Female patient, 91 years of age, was treated with Aldactone. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, anaemia, aspartate aminotransferase increased, asthenia, blood creatinine increased, blood potassium increased, blood sodium decreased, c-reactive protein increased, cardiac failure. Aldactone dosage: 25 MG (50 MG, INTERVAL: EVERY DAY) ORAL. During the same period patient was treated with IRBESARTAN, KARDEGIC, LASIX, PRAVASTATIN, NITRIDERM TTS, INSULATARD NPH, KAYEXALATE, XANAX. Patient was hospitalized. Patient recovered.

Aldactone Side Effects Report #5099798-1
Aldactone side effect was reported by a Physician from FRANCE on Aug 28, 2006. Female patient, 68 years of age, weighting 180.8 lb, was diagnosed with coma hepatic, back pain , bone pain and was treated with Aldactone. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, asthenia, balance disorder, blood creatinine increased, blood pressure systolic increased, hepatic encephalopathy, hepatomegaly, jaundice , nervous system disorder. Aldactone dosage: 50 MG (50 MG, EVERY DAY), ORAL. During the same period patient was treated with NEXIUM, ZOLPIDEM TARTRATE, DUPHALAC, ACETAMINOPHEN W, ACETAMINOPHEN W, VITAMIN B1 AND B6. Patient was hospitalized. Patient recovered.